These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks. Piña-Garza JE, Schiemann-Delgado J, Yang H, Duncan B, Hadac J, Hunter SJ. Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488 [Abstract] [Full Text] [Related]
46. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Shorvon SD, Löwenthal A, Janz D, Bielen E, Loiseau P. Epilepsia; 2000 Sep; 41(9):1179-86. PubMed ID: 10999557 [Abstract] [Full Text] [Related]
56. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA. Pediatrics; 2006 Aug 13; 118(2):e371-8. PubMed ID: 16847080 [Abstract] [Full Text] [Related]
58. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial. Genton P, Sadzot B, Fejerman N, Peltola J, Despland PA, Steinhoff B, Rektor I, Wroe S, Maubrey MC, Vandervelden C, van Hammée G, Schlit AF, van Paesschen W. Acta Neurol Scand; 2006 Jun 13; 113(6):387-94. PubMed ID: 16674605 [Abstract] [Full Text] [Related]